Leiden, Netherlands · Founded 2010 · Privately Held (backing)
Operator of a biotechnology company intended to provide technologies to expedite drug discovery and development processes. Ncardia is based in Leiden, Netherlands and was founded in 2010. Its last known valuation is $174 million. It has raised $130 million.
Last price · $/share
—
Implied valuation
$174.0M
Total raised
$129.7M
Last round
—
Cap table — not yet on record
Ncardia's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ncardia with a free account
·The complete investor list: 12 names
·Watch Ncardia: the Monday email on marks, rounds and moves
